Vir Biotechnology (VIR)
US Market

Vir Biotechnology (VIR) Financial Statements


Vir Biotechnology Financial Overview

Vir Biotechnology's market cap is currently ―. The company's EPS TTM is $-4.487; its P/E ratio is -2.14; Vir Biotechnology is scheduled to report earnings on February 22, 2024, and the estimated EPS forecast is $-1.01. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 2.64M$ 3.80M$ 46.71M$ -12.54M$ 371.43M
Gross Profit$ 2.60M$ 3.80M$ 44.80M$ 15.79M$ 349.18M
EBIT$ -166.59M$ -197.62M$ -143.19M$ -151.64M$ 194.96M
EBITDA-$ -195.90M$ -146.91M$ -157.31M$ 196.65M
Net Income Common Stockholders$ -163.41M$ -194.78M$ -140.90M$ -101.60M$ 175.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.69B$ 1.85B$ 2.24B$ 2.38B$ 2.35B
Total Assets$ 2.04B$ 2.24B$ 2.67B$ 2.80B$ 2.70B
Total Debt$ 114.12M$ 117.81M$ 121.46M$ 123.84M$ 131.06M
Net Debt$ -1.57B$ -1.73B$ -2.12B$ -2.26B$ -2.22B
Total Liabilities$ 369.81M$ 433.67M$ 695.13M$ 724.13M$ 546.12M
Stockholders Equity$ 1.68B$ 1.81B$ 1.97B$ 2.08B$ 2.15B
Cash Flow-
Free Cash Flow-$ -398.72M$ -132.65M$ -15.60M$ 98.91M
Operating Cash Flow$ -155.83M$ -389.27M$ -125.78M$ -15.60M$ 117.90M
Investing Cash Flow$ -58.95M$ 230.31M$ 98.08M-$ -662.61M
Financing Cash Flow$ 277.00K$ 3.18M$ 2.34M-$ 1.99M
Currency in USD

Vir Biotechnology Earnings and Revenue History

Vir Biotechnology Debt to Assets

Vir Biotechnology Cash Flow

Vir Biotechnology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis